AbbVie Inc (ABBV)
89.90
-2.37 -2.57%
NYSE
Oct 18, 20:00
Delayed 2m
USD
View All Key Stats
ABBV Key Stats
| Income Statement | |
| Revenue (TTM) | 30.95B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 4.04 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.449B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 76.64% |
| Profit Margin (Quarterly) | 23.96% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 136.13B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.631 |
| PE Ratio (TTM) | 22.25 |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 2.752B |
| Return on Equity (TTM) | Upgrade |
View All ABBV News
ABBV News
-
WireHeadlineTime (ET)
-
Yahoo10/18 17:40
-
Yahoo10/18 16:26
-
Globe Newswire10/18 16:01
-
Yahoo10/18 13:44
-
Globe Newswire10/18 10:00
-
Yahoo10/18 10:00
-
Yahoo10/18 09:45
-
SA Breaking News10/18 09:27
-
MT Newswires10/18 09:18
-
PR Newswire10/18 08:50
View All Events
ABBV Events
| Date | Type | Description |
|---|---|---|
| 01/25/2019 08:00 CST | Misc | AbbVie Inc Fourth Quarter Earnings Conference Call in 2018 |
| 01/25/2019 | Earnings | AbbVie Inc Fourth Quarter Earnings in 2018 Release |
| 11/02/2018 08:00 CDT | Misc | AbbVie Inc Third Quarter Earnings Conference Call in 2018 |
| 11/02/2018 | Earnings | AbbVie Inc Third Quarter Earnings in 2018 Release |
| 10/12/2018 | Dividends | Amount: 0.96, Declared Date: Sep 07 2018, Pay Date: Nov 15 2018 |
| 07/27/2018 09:00 EDT | Misc | AbbVie Inc Second Quarter Earnings Conference Call in 2018 |
| 07/27/2018 | Earnings | AbbVie Inc Second Quarter Earnings Results in 2018 |
| 07/12/2018 | Dividends | Amount: 0.96, Declared Date: Jun 15 2018, Pay Date: Aug 15 2018 |
| 05/04/2018 09:00 CDT | Misc | AbbVie Inc Annual General Meeting in 2017 |
| 04/26/2018 08:00 CDT | Misc | AbbVie Inc First Quarter Earnings Conference Call in 2018 |
ABBV Fundamentals
Income Statement View Statement
ABBV Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ABBV One Page Reports
- One Page Report Download
ABBV Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 89.90 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.abbvie.com
- Investor Relations URL: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-IRHome
- HQ State/Province: Illinois
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Nov. 02, 2018
- Last Earnings Release: Jul. 27, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Oct. 12, 2018
- Description: AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
ABBV Excel Add-In Codes
- Name: =YCI("ABBV","name")
- Description: =YCI("ABBV","description")
- Sector: =YCI("ABBV","sector")
- Industry: =YCI("ABBV","industry")
- Est. Current Fiscal Year End: =YCI("ABBV","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ABBV Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABBV Tweets Stocktwits
Advertisement
